Based on present evidence, it remains unclear whether increased insulin resistance or reduced endogenous insulin secretion (or both) is underlying mechanisms in sarcopenia and frailty (Cleasby et al., 2016; Tanaka, Kanazawa, & Sugimoto, 2015). The gene discussed is INS; the disease is sarcopenia.